The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

Rising biologics demand is likely to fuel innovation in biopharmaceutical contract manufacturing, propelling the market during the forecast period.

The global biopharmaceuticals contract manufacturing market is expected to grow from $16.54 billion in 2022 to $18.31 billion in 2023 at a compound annual growth rate (CAGR) of 10.6%. The global biopharmaceuticals contract manufacturing market size is expected to reach $26.88 billion in 2027 at a CAGR of 10%.

Get A Free Sample On The Global Biopharmaceuticals Contract Manufacturing Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10181&type=smp

Global Biopharmaceuticals Contract Manufacturing Market Segments Include:

• By Product: Biologics, Monoclonal Antibodies (MABs), Recombinant Proteins, Vaccines, Antisense, RNAi, And Molecular Therapy, Biosimilars
• By Source: Mammalian, Non-mammalian
• By Service: Process Development, Fill And Finish Operations, Analytical And QC studies, Packaging
• By Application: Clinical, Commercial
• By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, North America is the largest region in the global biopharmaceuticals contract manufacturing market in 2021.

Major Market Players in the biopharmaceuticals contract manufacturing market include Boehringer Ingelheim GmbH, Lonza Group, Inno Biologics Sdn Bhd, Rentschler Biotechnologie GmbH, Samsung BioLogics, AGC Biologics, ProBioGen AG.

Product innovations are a hot trend in the biopharmaceuticals contract manufacturing sector. To maintain their market position, major players in the biopharmaceutical contract manufacturing sector are introducing unique products. For example, in February 2023, Thermo Fisher Scientific, a biotechnology research company based in the United States, and Elektrofi, a biotechnology company based in the United States that specialises in drug formulation and delivery innovations, entered into a strategic contract manufacturing agreement to support the commercial production of Elektrofi’s ground-breaking ultra-high concentration subcutaneous products. Elektrofi’s innovative microparticle technology allows for small-volume injections of biologics such as monoclonal antibodies, therapeutic proteins, and other large-molecule drugs that are critical to human health. Elektrofi’s platform technology enables patients to self-inject pharmaceuticals at home rather than in a hospital setting, solving the challenges associated with giving biologic-based therapies.

The Biopharmaceuticals Contract Manufacturing Global Market Report 2023  provides a biopharmaceuticals contract manufacturing market overview for the time series: historic years (2010 – 2021) and ten years forecast (2023 – 2032). The biopharmaceuticals contract manufacturing market forecast analyzes biopharmaceuticals contract manufacturing market size, biopharmaceuticals contract manufacturing market share, leading competitor market positions. The regions covered in the report include Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa and the countries include Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Biopharmaceutical contract manufacturing is the process through which a biopharmaceutical business employs a third-party manufacturer to manufacture its pharmaceuticals or biologic products on its behalf. It is used when pharmaceutical companies use other companies’ facilities to manufacture drugs under their own brand. It’s the same as private label or third-party manufacture.

Explore Similar Reports From The Business Research Company:

Contract Research And Manufacturing Services (CRAMS) Global Market Report 2023

Bio-Pharmaceutical Logistics Global Market Report 2023

Biosimilar Monoclonal Antibodies Global Market Report 2023

Learn More About The Business Research Company
The Business Research Company has published over 3000+ detailed industry reports, spanning over 3000+ market segments and 60 geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: